Abstract
Sodium (23Na) MRI proffers the possibility of novel information for neurological research but also particular challenges. Uncertainty can arise in in vivo 23Na estimates from signal losses given the rapidity of T2* decay due to biexponential relaxation with both short (T2*short) and long (T2*long) components. We build on previous work by characterising the decay curve directly via multi-echo imaging at 7 T in 13 controls with the requisite number, distribution and range to assess the distribution of both in vivo T2*short and T2*long and in variation between grey and white matter, and subregions. By modelling the relationship between signal and reference concentration and applying it to in vivo 23Na-MRI signal, 23Na concentrations and apparent transverse relaxation times of different brain regions were measured for the first time. Relaxation components and concentrations differed substantially between regions of differing tissue composition, suggesting sensitivity of multi-echo 23Na-MRI toward features of tissue composition. As such, these results raise the prospect of multi-echo 23Na-MRI as an adjunct source of information on biochemical mechanisms in both physiological and pathophysiological states.
Introduction
In the physiological state, the maintenance of the transmembrane sodium (23Na) concentration gradient (10–15 mM intracellular sodium concentration and ~140 mM extracellular sodium concentration) is a precondition for several critical cellular functions. These include the transport of ions, neurotransmitters and nutrients; regulation of osmotic and electrostatic forces on cells and macromolecules; as well as the transmission of action potentials1–3. In the diseased state, multiple pathological pathways can lead to aberrations of these functions. Such alterations can lead to changes in intra- and extracellular concentrations due to a reduced ability to maintain resting conditions and due to conformational changes in cells themselves as well as the cellular environment in which they are embedded. Thus, 23Na-MRI is a potential source of more direct and quantitative biochemical information than is generally possible with conventional proton (1H) MRI4. As such, there is substantial interest in 23Na-MRI regarding a range of neurological conditions despite the additional complications of acquiring 23Na-MRI signal, including stroke5, epilepsy6, tumors7 and neurodegenerative diseases8–12.
The quadrupolar 23Na nucleus (spin = 3/2) is subject to the influence of fluctuations in neighbouring electric fields due to net positive and non-uniform distribution of charge3,13–15. In the presence of a magnetic field, 23Na nuclei exhibit four discrete energy states, with three possible (single quantum, SQ) transitions (−1/2, +1/2 “central transition”; −3/2, −1/2 and 1/2, 3/2 “satellite transitions”). In highly motile environments such as plasma or cerebrospinal fluid (CSF), the correlation time (τC) is much shorter than the Larmor period (ω0−1) (ω0∙ τC ≪ 1), leading to monoexponential longitudinal (T1) and transverse (T2) relaxation. This is in contrast to tissue environments such as within cells and the interstitial spaces between cells where diffusion is restricted by interactions of the 23Na cation with macromolecular anions. Such interactions modulate decay behaviour in a measurable way: the satellite transitions are subject to additional fast relaxation processes so that both T1 and T2 reflect biexponential decay. Literature T2 estimates in brain parenchyma are in the range ~0.5–5 ms and ~15–30 ms for the short and long components of biexponential decay, respectively2.
In the environments that give rise to biexponential behaviour, further transitions beyond SQ coherences (SQC) are possible. Such double and triple quantum coherences (D/TQC) can be selectively detected by appropriate multiple quantum filtering (MQF), and thus provide a source of information regarding short and long components of T2* decay. However, there is a strong penalty in terms of signal-to-noise ratio (SNR) and resolution for a given acquisition length2. Inversion recovery (IR) methods16–18 can be used to suppress signal arising from unrestricted aqueous environments such as CSF spaces, though interstitial extracellular areas are not ‘unrestricted’ environments and therefore suppression is incomplete. Furthermore, measurement of concentration remains an unachieved goal for IR methods3,15. Both MQF and IR imaging may be argued to provide an unspecified weighting toward intracellular signal beyond the weighted average obtained when measuring the total tissue sodium concentration (TSC). However, all 23Na-MRI methods continue to receive contributions from intracellular and extracellular spaces3,14,15.
Crucially, the rapid decay of the short component of T2 (T2*short) has direct consequences for the accuracy and SNR of 23Na-MRI19, leading to signal losses of up to 60%. As such, 23Na-MRI acquisition schemes involving ultra-short echo times (UTE, ~0.2 ms) developed as a strategy that minimises uncertainty in T2 signal loss due to biexponential relaxation20,21. However, this does not address variation in T2 that may be influenced by methodological or physiological factors. The latter in particular may be of interest in the interpretation of 23Na-MRI signal as a measure of healthy and aberrant biochemical function. Accurate in vivo multi-echo relaxometry techniques may provide an adjunct source of information regarding the contribution and distribution of T2*short and T2*long. Previous attempts to characterise in vivo brain T2 decay times have been conducted at lower field strengths with lower sampling rates in the temporal domain without separating multiple T2* components22–24, or at higher fields only provide estimates of T2*long25,26 or did not consider variation between tissue types (white matter, WM; grey matter, GM)18 or between different regions27,28.
Here, we designed a novel approach based on the density adapted radial sequence29, at 7 T with multiple-echoes (n = 24) (Fig. 1) ensuring echo time (TE) sampling with the requisite number, distribution and range to robustly assess the distribution of both in vivo T2*short and T2*long through biexponential modelling. Modelling was applied to empirical estimates of sodium signal in healthy volunteers between WM and GM and, for the first time, among several subcortical regions. In addition the fraction of signal or magnetization (M0) at short TEs (M0SF) and at long TEs (M0LF) was converted to concentrations, by modelling the relationship between 23Na signal (M0) and concentration (mM) in reference tubes. As such, in vivo 23Na concentrations (NaSF, NaLF) corresponding to different signal fractions for the various tissues and regions were provided for the first time (Fig. 2).
Results
Figure 2 provides an overview of the workflow applied to data, including the extraction of decay time components (T2*short and T2*long), concentrations (NaSF, NaLF), total sodium concentration (TSC) and extracellular fraction (EcF). See Table 1 for mean estimates of each parameter for each tissue type and region.
Table 1.
T2*short (ms) | T2*long (ms) | NaSF (mM) | NaLF (mM) | TSC (mM) | EcF | ||
---|---|---|---|---|---|---|---|
GM | Mn | 4.99 | 31.51 | 21.16 | 25.75 | 46.92 | 0.18 |
s.d | 0.41 | 1.78 | 0.87 | 2.97 | 2.83 | 0.02 | |
WM | Mn | 4.44 | 38.25 | 22.28 | 15.87 | 38.15 | 0.11 |
s.d | 0.34 | 2.45 | 0.97 | 1.49 | 1.97 | 0.01 | |
Thalamus | Mn | 3.70 | 40.13 | 24.28 | 16.02 | 40.30 | 0.11 |
s.d | 0.41 | 7.50 | 1.66 | 2.85 | 2.33 | 0.02 | |
Putamen | Mn | 3.72 | 32.66 | 23.04 | 13.25 | 36.29 | 0.09 |
s.d | 0.61 | 7.00 | 2.82 | 3.19 | 1.76 | 0.02 | |
Pallidum | Mn | 2.82 | 31.62 | 21.99 | 11.25 | 33.24 | 0.08 |
s.d | 0.44 | 6.87 | 2.08 | 2.62 | 2.62 | 0.02 | |
Caudate | Mn | 4.00 | 34.79 | 19.26 | 17.80 | 37.06 | 0.13 |
s.d | 0.61 | 6.37 | 2.10 | 2.95 | 2.09 | 0.02 | |
Corpus Callosum | Mn | 3.48 | 39.82 | 19.57 | 15.96 | 35.52 | 0.11 |
s.d | 0.42 | 9.16 | 3.30 | 4.87 | 3.35 | 0.03 | |
Cerebellar WM | Mn | 3.57 | 35.51 | 16.29 | 12.31 | 28.60 | 0.09 |
s.d | 0.81 | 7.26 | 2.34 | 2.35 | 2.88 | 0.02 | |
Centrum Semiovale | Mn | 4.37 | 54.74 | 23.93 | 8.46 | 32.39 | 0.06 |
s.d | 0.43 | 14.98 | 2.83 | 1.68 | 2.74 | 0.01 | |
Pons | Mn | 2.43 | 31.52 | 13.19 | 11.99 | 25.18 | 0.09 |
s.d | 0.58 | 11.45 | 3.68 | 3.53 | 3.17 | 0.03 |
Goodness of fit indicated high performance of the biexponential decay model across the 10 ROIs including complete GM and WM segmentations and eight sub-cortical ROIs (mean r2 = 0.97 ± 0.01(s.d.)). The mean proportion of the signal fraction (f) associated with the short T2* component to total signal estimated by the biexponential model is 57.7% ± 0.07 (s.d.). There was also variation among ROIs (Fig. 3) with the overall highest value obtained for the centrum semiovale (70% ± 0.04 (s.d.)). The caudate nucleus (52% ± 0.06 (s.d.)) and pons (52% ± 0.1 (s.d.)) jointly provide the lowest estimates among subcortical regions, while the lowest mean estimate across all ROIs was for the entire GM segmentation (46% ± 0.03(s.d.)).
T2*short and T2*long differences between white and grey matter
Table 2a provides results for the whole model (ANOVA, corrected at P < 0.008) and main effects of Tissue Type (GM, WM) for each parameter. Effects of Age and Sex were not found to be significant for any parameter. Significant effects were observed for whole model for T2*long (P < 0.0001) and T2*short (P = 0.005) as well significant effects of tissue type for T2*long (P < 0.0001) and T2*short (P = 0.001).
Table 2.
F-Values | |||||
---|---|---|---|---|---|
Dependant variable | Whole Model (3) | Tissue Type (1) | Sex (1) | Age (1) | |
a) | T2*short | 5.75 | 14.39 | — | — |
T2*long | 26.07 | 72.95 | — | — | |
NaSF | — | — | — | — | |
NaLF | 36.7 | 109.63 | — | — | |
TSC | 29.25 | 85.33 | — | — | |
EcF | 36.7 | 109.31 | — | — | |
Dependant variable | Whole Model (9) | Region (7) | Sex (1) | Age (1) | |
b) | T2*short | 12.44 | 15.97 | — | — |
T2*long | 7.23 | 9 | — | — | |
NaSF | 24.41 | 30.02 | — | — | |
NaLF | 9.5 | 12.13 | — | — | |
TSC | 37.36 | 46.64 | 8.03 | — | |
EcF | 9.5 | 12.13 | — | — |
Results of post-hoc Steel-Dwass tests are detailed in Table 3 and represented in Fig. 4. Significantly higher (z = −3.03, P < 0.003) values of T2*short were observed in GM (4.99 ms ± 0.41(s.d.)) versus WM (4.44 ms ± 0.34(s.d.). Conversely, higher T2*long estimates were observed in WM (38.25 ms ± 2.45 (s.d.)) versus GM (31.51 ms ± 1.78(s.d.)) (z = 4.31, P < 0.0001).
Table 3.
Th | Pu | Pa | Ca | Cc | Cb | Cs | Po | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
T2*short | Th | ******** | — | — | — | — | — | — | — | Th | T2*long |
Pu | — | ******** | — | — | — | — | —3.59,0.008 | — | Pu | ||
Pa | 3.79,0.004 | — | ******** | — | — | — | −3.79,0.004 | — | Pa | ||
Ca | — | — | −3.74,0.005 | ******** | — | — | — | — | Ca | ||
Cc | — | — | — | — | ******** | — | — | — | Cc | ||
Cb | — | — | — | — | — | ******** | — | — | Cb | ||
Cs | — | — | −4.31,0.0004 | — | 3.74,0.005 | — | ******** | — | Cs | ||
Po | 4.21,0.0007 | 3.9,0.003 | — | −4.15,0.0009 | −3.95,0.002 | — | −4.31,0.0004 | ******** | Po | ||
Th | Pu | Pa | Ca | Cc | Cb | Cs | Po | ||||
NaSF | Th | ******** | — | — | — | — | — | 4.21,0.0007 | — | Th | NaLF |
Pu | — | ******** | — | — | — | — | 3.64,0.007 | — | Pu | ||
Pa | — | — | ******** | —3.95,0.002 | — | — | — | — | Pa | ||
Ca | 4.31,0.0004 | — | — | ******** | — | —3.79,0.004 | —4.3,0.0004 | —3.74,0.005 | Ca | ||
Cc | — | — | — | — | ******** | — | —4,0.002 | — | Cc | ||
Cb | 4.31,0.0004 | 3.9,0.003 | 4.15,0.0009 | — | — | ******** | — | — | Cb | ||
Cs | — | — | — | 3.85,0.003 | — | 4.31,0.0004 | ******** | —3.64,0.007 | Cs | ||
Po | 4.31,0.0004 | 4.15,0.0009 | —4.21,0.0007 | —3.69,0.006 | — | — | −4.31,0.0004 | ******** | Po | ||
Th | Pu | Pa | Ca | Cc | Cb | Cs | Po | ||||
TSC | Th | ******** | — | — | — | — | — | 4.21,0.0007 | — | Th | EcF |
Pu | 3.74,0.005 | ******** | — | — | — | — | 3.64,0.007 | — | Pu | ||
Pa | 4.25,0.0005 | — | ******** | −3.95,0.002 | — | — | — | — | Pa | ||
Ca | — | — | — | ******** | — | −3.79,0.004 | −4.3,0.0004 | −3.74,0.005 | Ca | ||
Cc | — | — | — | — | ******** | — | −4, 0.002 | — | Cc | ||
Cb | 4.31,0.0004 | 4.31,0.0004 | — | −4.31,0.0004 | 3.9, 0.003 | ******** | −3.64,0.007 | — | Cb | ||
Cs | 4.31,0.0004 | — | — | — | — | — | ******** | — | Cs | ||
Po | 4.31,0.0004 | 4.31,0.0004 | −3.85,0.003 | −4.31,0.0004 | −4.1,0.001 | — | −3.85,0.003 | ******** | Po | ||
Th | Pu | Pa | Ca | Cc | Cb | Cs | Po |
T2*short and T2*long differences between sub-cortical regions
ANOVAs revealed significant (P < 0.0001) effects for both the whole model and the effect of Region (Table 2b) on both T2*short and T2*long. Overall, in terms of the post-hoc analysis (Table 3, Fig. 4b), we observed substantial variation for each parameter between subcortical regions. The shortest mean decay time components were observed in the pons for both T2*short (2.43 ms ± 0.58(s.d.)) and T2*long (31.52 ms ± 11.45(s.d.)), with the longest observed in the centrum semiovale (T2*short: 4.37 ms ± 0.43(s.d.); T2*long: 54.74 ms ± 14.98(s.d.)). The centrum semiovale also evidenced a wide distribution of T2*long estimates between subjects.
Concentration differences between white and grey matter
The whole model and the main effect of tissue type were significant (P < 0.0001) for NaLF, TSC and EcF. Whole model and tissue type effects for NaSF did not survive correction for multiple comparisons. Post-hoc Steel-Dwass tests revealed significantly higher values in GM versus WM for NaLF (25.75 mM ± 2.97(s.d.), 15.87 mM ± 1.49(s.d.); z = −4.31, P < 0.0001), extracellular fraction (0.18 ± 0.02(s.d.), 0.11 ± 0.01(s.d.); z = −4.31, P < 0.0001) and TSC (46.92 mM ± 2.83(s.d.), 38.15 mM ± 1.97(s.d.); z = −4.31, P < 0.0001).
Concentration differences between sub-cortical regions
Both NaSF and NaLF, as well as TSC and EcF, demonstrated significant (P < 0.0001) effects for both the whole model and the effect of Region. A significant effect of Sex was also observed for TSC (P = 0.006). As above, concentrations and derived metrics showed a variety of variations between regions. The thalamus demonstrated the highest mean estimates of NaSF (24.28 mM ± 1.66(s.d.)) and TSC (40.30 mM ± 2.33(s.d.)), with the lowest estimates observed in the pons (NaSF: 13.19 mM ± 3.68(s.d.); TSC: 25.18 mM ± 3.17(s.d.)). The caudate (NaLF: 17.80 mM ± 2.95(s.d.); EcF: 0.13 ± 0.02(s.d.)) and centrum semiovale (NaLF: 8.46 mM ± 1.68(s.d.); EcF: 0.06 ± 0.01 (s.d.)), provided the highest and lowest estimates, respectively, for both NaLF and EcF. Inter-subject variability was especially present for EcF and NaLF in the corpus callosum.
Discussion
Data from a multi-echo 23Na radial sequence acquired at ultra-high field (UHF) were analysed using a biexponential relaxation model to derive T2*short and T2*long relaxation times. In addition, 23Na concentrations apparent at short and long TEs were quantified. As such, to our knowledge, we provide the first 23Na-MRI data to address regional variation in T2*short at UHF, and to quantify the apparent 23Na concentrations corresponding to short and long signal fractions associated with the respective components of T2* relaxation. Given the interest in 23Na-MRI particularly for neurological research, quantification of these parameters and characterisation of their variation is necessary as an adjunct to even standard UTE 23Na-MRI protocols.
The overall contribution of short and long T2* components to the measured sodium signal is considered to be ~60% to 40%2, respectively, consistent with our mean estimate of 57.7% ± 0.07% (s.d.) for the signal fraction associated with the short T2* component (f) across all considered ROIs. In the biexponential relaxation model applied here contributions of different T2* components were not fixed. The model revealed that while f was comparable to the general estimate in some regions (eg the entire WM), it varied in others (eg. the lowest signal contributions over the entire GM) (Fig. 3). Additionally, variation was observed across sub-cortical ROIs which are themselves likely to include diverse proportions of grey and white matter. Examples include regions that mainly contain white matter tracts but also grey matter nuclei (eg. Pons), as well as the inverse (eg. thalamus). Deviation from the theoretical ratio of 60:40 may reflect the contribution of additional compartments, for example an increased contribution of highly motile ions pool in CSF where signal decay is monoexponential (eg T2* ~ 47 ms)27. Higher estimates of f may reflect reduced contributions of this type, for example in the centrum semiovale which provided the highest signal fraction associated with the short T2* component observed here.
T2* relaxation refers to the dephasing of collections of nuclei due to reciprocal interactions of their local magnetic fields (T2) in addition to magnetic field inhomogeneities (T2’)30. Attempts to characterize in vivo 23Na relaxation times in human brain tissue have been made for several decades22,24. Such applications show variation in terms of applied methods, following developments in sequence design and the availability of higher field strengths. These factors are especially important for 23Na, given not only the relative rapidity of biexponential relaxation but also due to its lower concentration and intrinsic sensitivity compared to 1H. This leads to a relatively lower SNR in 23Na-MRI, which can be partly compensated for by higher fields3,31. Consequently, among studies that attempt to quantify either long or short components of T2* relaxation in brain tissues (for an overview see Table 4), progressively higher fields have been employed. At 4 T, values of T2*long were observed to vary little between cortical GM and WM ROIs, though with some evidence of variation in subcortical regions (thalamus) and higher values in some white matter structures like the corpus callosum (CC)25. In line with theoretical expectations, and as observed in animal experiments32, longer relaxation times are observed at the higher field strengths in the current data (Table 1) and more generally at 7 T (Table 4). At 7 T, despite the lack of variation in T2*long values between general GM and WM ROIs, variation among other sub-regions comparable to the relative levels of T2*long seen in the current work was observed (thalamus > CC > cerebellar WM > putamen)26. Due to insufficient data points to characterize the initial portion of the decay curve, given that the smallest TEs are > 3 ms, these studies did not attempt to quantify T2*short. Thus the possibility of an unknown bias in measurement, relative to studies that model both T2* components remains. In a 7 T study in healthy controls of both T2*short and T2*long in white matter, estimates in excellent agreement with the current data were observed by Nagel et al.18. More recent data27 in five subjects provide similarly concordant data for GM, though some disagreement for relative T2*short relaxation times between tissues should be noted. Recently, Blunck et al.28 validated a multi-echo sequence with a large numbers of TEs, estimating decay components in 4 subjects, and observe T2*short relaxation times that are within the range of those seen here, as well as less variation between GM and WM for T2*long. The principal methodological differences between this study and the previous studies characterising both T2*short and T2*long in GM and WM at 7 T, beyond a slightly larger sample, is the distribution of early TEs during the first part of the decay curve thought to be dominated by the short T2* component. For example the three shortest TEs correspond to 0.3–0.8–2.3 ms here, versus 0.4–4.5–8.5 ms for Blunck et al.28 and 0.35–1–1.5 ms for Niesporek et al.27. The echo time choices made here are dictated by the minimum inter-echo spacing of about 6 ms. With 3 separate acquisitions there is additional flexibility in the TE choices. The approach adopted was to use logarithmic spacing for the first echoes and equal spacing for later echoes. Logarithmic spacing on the early echoes provides good sensitivity to a range of T2*short values. The current data suggest that GM and WM give rise to significantly different time constants of decay, and do so differentially for short and long T2* components. These considerations, in addition to the variation among subregions and between T2* components for given regions, raise the possibility of the influence of tissue composition on observed relaxation (discussed below).
Table 4.
Structure | Ref | Field Strength (T) | TE n:range (ms) | T2*short (ms) | T2*long (ms) | ||
---|---|---|---|---|---|---|---|
GM | WM | GM | WM | ||||
Brain Parenchyma | 25 | 4 | 10: 3.8–68.7 | — | — | 21.1 ± 0.5 | |
26 | 7 | 2: 12–32 | — | — | 28 ± 2 | 29 ± 2 | |
18 | 7 | 56: 0.35–55 | — | 4.7 ± 0.2 | — | 40 ± 2 | |
28 | 7 | 38: 0.4–150 | 2.02 ± 1.67 | 1.99 ± 2.09 | 25.9 ± 8.3 | 22.4 ± 7.8 | |
27 | 7 | 32: 0.35–85 | 5.4 ± 0.2 | 3.5 ± 0.1 | 36.4 ± 3.1 | 23.3 ± 2.6 | |
Frontal lobe | 26 | 7 | 2: 12–32 | — | — | 27 ± 2 | 31 ± 1 |
Prefrontal | 25 | 4 | 10: 3.8–68.7 | — | — | 21.2 ± 2.2 | 19.3 ± 2.9 |
Occipital Lobe | 26 | 7 | 2: 12–32 | — | — | 29 ± 1 | 28 ± 1 |
25 | 4 | 10: 3.8–68.7 | — | — | 22 ± 2.4 | — | |
Parietal lobe | 25 | 4 | 10: 3.8–68.7 | — | — | — | 18.2 ± 1.9 |
Insula | 25 | 4 | 10: 3.8–68.7 | — | — | 21.6 ± 1.2 | — |
External capsule | 25 | 4 | 10: 3.8–68.7 | — | — | — | 18.3 ± 2.9 |
Thalamus | 26 | 7 | 2: 12–32 | — | — | 32 ± 2 | — |
25 | 4 | 10: 3.8–68.7 | — | — | 16.9 ± 2.4 | — | |
Putamen | 26 | 7 | 2: 12–32 | — | — | 23 ± 2 | — |
Peri-ventricle WM | 26 | 7 | 2: 12–32 | — | — | — | 34 ± 1 |
Cerebellum | 26 | 7 | 2: 12–32 | — | — | — | 24 ± 1 |
Splenium of CC | 26 | 7 | 2: 12–32 | — | — | — | 28 ± 2 |
CC | 25 | 4 | 10: 3.8–68.7 | — | — | — | 22 ± 2.7 |
CSF | 26 | 7 | 2: 12–32 | 54 ± 4 | |||
25 | 4 | 10: 3.8–68.7 | 63.7 ± 4.7 | ||||
28 | 7 | 38: 0.4–150 | 57.2 ± 6.6 | ||||
18 | 7 | 56: 0.35–55 | 56 ± 4 | ||||
27 | 7 | 32: 0.35–85 | 46.9 ± 2.1 |
By modelling the relationship between signal (M0) and known reference concentrations, we obtained – from estimates of M0SF and M0LF derived from in vivo data – quantitative values for the apparent 23Na (NaSF, NaLF) concentrations relating to short (f) and long (1-f) signal fractions (Fig. 2). NaSF was observed to be comparable between GM (21.16 mM ± 0.87(s.d.)) and WM (22.28 mM ± 0.97(s.d.)). These values are higher than the reference intracellular sodium concentration (10–15 mM) commonly cited in the literature1–3, possibly reflecting contributions from extracellular spaces. Various attempts have been made to weight measures of concentration toward the restricted sodium pool. For example, subtraction of only two SQ sodium images as a means of suppressing contributions from the long T2* component obtains a concentration of 25.9 ± 1.2 mM for bound sodium in the ‘healthy’ GM of patients with brain tumours33. This estimate is not dissimilar to our estimates of GM though most similar to the NaLF concentration we observe in WM (Table 1). Recent studies – utilizing IR at 3T4,34 and TQF at UHF10,35 – find little difference in concentration estimates weighted toward the restricted pool between GM and WM in their healthy control comparison samples. This is consistent with the similarity between our estimates of NaSF from whole tissue type segmentation maps for GM (21.16 mM ± 0.87(s.d.) and WM (22.28 mM ± 0.97(s.d.)) (Fig. 4a). Similarly, attempts to measure volume fractions associated with bound sodium (WM > GM)10,35, are complementary with the current work’s estimate of sodium extracellular fraction (GM > WM) derived from NaLF. Indeed, the sodium EcF estimates observed here (0.06–0.18) fall well within the expected overall volume fraction of the extracellular space in healthy adult brains (0.2) derived from a variety of methods36. Furthermore, they specifically correspond to previous estimates of greater 23Na extracellular volume fractions in grey versus white matter using 23Na-MRI4,34.
Most in vivo studies of brain 23Na-MRI provide estimates in terms of total sodium concentration (TSC), thus we computed an equivalent metric to permit comparison. Estimates here (GM: 46.92 mM ± 2.83 (s.d.); WM: 38.15 mM ± 1.97 (s.d.)) fall well within the literature range for TSC in GM (30–70 mM) and WM (20–60 mM)2,14. Specifically, in the majority of studies that report healthy control values in GM, TSC is observed to exhibit higher values compared to WM, including across field strengths and different acquisitions8,10,12,37–40. Niesporek et al.41, employing a partial volume correction method adapted from PET accounting for both point spread function spreading and resolution issues in 23Na-MRI, suggest corrected TSC values for GM (48 mM ± 1 (s.d.)) and WM (43 mM ± 3(s.d.)) notably similar to our estimates. Where available, regional TSC estimates in healthy controls are concordant with the current results in terms of finding higher values in the thalamus and caudate compared to putamen and pallidum as well as much lower values in the cerebellum11, and specifically its white matter37. The correspondence of our observed TSC values (the sum of NaSF and NaLF) and those in the literature are encouraging, suggesting that the current methods appropriately characterize the overall 23Na signal with respect to the rest of the literature. This lends further credence to the signal fractions and concentrations associated with the short and long T2* components as observed here. Crucially, the current methods achieve this without a high SNR penalty and permit quantification.
Relaxation is influenced by factors constraining molecular motion as well as the structure and content (tissue density) of the molecular environment experienced by nuclei30. For example, one factor of tissue density is water/fluid content which can be explored via invasive electrophysiological measures of impedance42, in vivo MRI estimates of proton density43 and post-mortem wet-to-dry mass ratios44. Higher water/fluid content is observed in GM tissues versus WM, and particularly in the caudate among sub-cortical regions explored here. This may be reflected here by lower signal fractions associated with the short T2* component observed in GM and the caudate in the current data (Fig. 3), and inversely higher values of NaLF and the related metric EcF (Table 1, Fig. 4). Conversely, the white matter ROI in the centrum semiovale provides the highest short signal fraction (f) and the lowest estimates of NaLF and EcF.
The extent and an-/isotropy of the mobility of nuclei also impacts relaxation, with the structure and cellular make-up and the constituents of intracellular and extracellular environments all potentially playing a role. The fluid environment in the interstitium between brain cells differs from the environment of CSF in the ventricles due to the presence of the negatively-charged long-chain molecules of the extracellular matrix36,45. The extracellular matrix regulates the ionic environment necessary for cellular functions such as synaptic transmission and action potentials, interacts with diffusion through extracellular spaces via viscous drag and the interaction with positive charged ion species such as 23Na, and varies in composition and density across brain structures3,36,45. The properties of the extracellular space and matrix are in turn influenced by cellular populations of neurons and glia, in terms of the distribution of different subtypes and the manner in which they constrain the structure of their environment via the formation of sheets, extension of processes and size alterations influencing the volume of intra-/extracellular spaces36.
Estimates from histology, DNA extraction and immunocytochemistry suggest that the human brain contains ~100 billion neurons and an equivalent number of non-neuronal cells including glia (oligodendrocytes > astrocytes > microglia)46 and a small proportion of endothelial cells, leading to an approximate overall glia-to-neuron ratio (GNR) of 1:147. At the same time, GNRs vary widely between brain regions with extremes including the cerebellum (0.23) due to its small, densely packed neurons, while reaching 11.35 in other regions of the brain including brainstem, diencephalon and striatum (i.e. many of the subregions considered here)47–50. These variations are thought not to reflect differences in glia density, which varies much less between structures, but rather with increasing neuronal density that is itself due to decreasing neuronal cell size (including soma and dendritic and axonal arborisations)47,49. 500-fold variation in average neuronal cell masses are observed across structures and species versus 1.4-fold for glia48. The above evidence suggests that while the WM represents a restrictive environment determined mainly by the anisotropy51 of axons and small-bodied46 myelin-supporting oligodendrocytes, the GM represents a wider variety of cellular environments especially given the range of neuronal sizes. This is a possible explanation for the variation in relaxation times, associated signal fractions and derived metrics observed here. Similarly, these factors may contribute to the variation between regions (Fig. 4) to the extent that they reflect proportions of white and grey matter. It is notable that T2*short and T2*long, as well as NaLF tend to be lowest in axon/myelin-rich structures. This is most evident across metrics in the pallidum and pons, but also to some extent in centrum semiovale, cerebellar white matter and the corpus callosum. It should be recognized that variability across metrics among these regions suggests additional factors at work as well.
Considering concordance of our results and the available relevant literature, in addition to recent insights into tissue composition, this raises the prospect of multi-echo 23Na-MRI’s sensitivity to microstructural properties of imaged tissues. Future work, including additional measures of microstructure, such as via the measurement of the diffusion properties of 1H or 23Na itself14,15,18,52, could confirm and expand the current results, and speak to limitations of the current approach. For example, despite the measures taken to avoid partial volume effects, as is the case for all 23Na-MRI there is a remaining possibility of an unknown bias due to the influence of higher concentrations of 23Na in extracellular and cerebrospinal fluid, and the possibility of differences between tissue types in terms of this bias. Further gains in spatial resolution could further ameliorate this issue3, as well as the application of partial volume correction methods originally applied in positron emission tomography and recently adapted to 23Na-MRI27,41. Given the duration of the scan required to characterise the decay curve, there is the possibility of artefacts arising from subject motion. Measures such as the use of foam supports to support subjects’ heads and constrain movement were employed; however optimisation of the sequence to shorten overall acquisition times should be pursued. In any case, this will be required for clinically feasible scan times.
In summary, we provide evidence that in the physiological state multi-echo 23Na-MRI depicts variation in T2* relaxation between major distinctions in tissue structure – GM and WM – as well as between diverse brain regions of differing composition and structure. This includes variations in decay times, including the T2*short component. Additionally, quantification of 23Na concentrations apparent at short and long TEs was evaluated via a quantitative multi-echo approach for the first time. This provides a foundation for the examination of the alteration of these properties in pathophysiological populations, as a means of shedding light on both disease processes and the mechanisms underlying normal ionic homeostatic mechanisms as imaged by 23Na-MRI.
Methods
Subjects
14 healthy subjects with no history of neurological or psychiatric illness provided informed consent and were enrolled in the protocol, as approved by the local Ethics Committee (Comité de Protection des Personnes sud Méditerranée 1). All methods were performed in accordance with the relevant guidelines and regulations. Due to excessive movement in one subject, the final sample consisted of n = 13 subjects (5 female) (mean age: 23.9 ± 3.6 (s.d.) years, range: 20–32).
MRI acquisition
Data were acquired on a whole-body 7 T Magnetom MR system (Siemens, Erlangen, Germany). 23Na-MRI was acquired using a dual-tuned 23Na/1H QED birdcage coil and a multi-echo density adapted 3D projection reconstruction pulse sequence (TR = 120 ms, 10000 spokes, 384 radial samples per spoke, radial fraction p of 0.32, 500 us hard RF pulse, bandwidth 200 Hz/pixel, 3.5 mm nominal isotropic resolution, 8 echoes, acquisition time = 20 min). To ensure a sufficient number and distribution of TEs, especially for measuring T2*short, while taking into account the 5 ms readout of the sequence, we applied the sequence three times in one exam in order to obtain 24 TEs ranging from 0.3 ms to 100 ms (Run 1: 0.3–6.3–13–19–25–31–54–89 ms; Run 2: 0.8–7–12–17–23–35–45–80 ms; Run 3: 2.3–9.7–15–21–28–40–66–100 ms). The three first subjects underwent an exam of 23 TEs across the same range (Run 1: 0.3–6.3–13–19–25–31–50–100 ms; Run 2: 2–7–12–17–23–40–45–80 ms; Run 3: 3–9–15–22–28–34–70 ms). Six cylinder tubes filled with 2% agar gel doped with a range of sodium concentrations (10–75 mM) were arrayed in the field of view in front of the subject’s head as external references for quantitative assessment of brain sodium concentration. Foam cushions were used to immobilize and support the head as well as the external references.
1H-MRI was performed during the same session as 23Na-MRI after a short pause to permit the changing of head coils. A high-resolution proton MRI 3D-MP2RAGE (TR = 5000 ms/TE = 3 ms/TI1 = 900 ms/TI2 = 2750 ms, 256 slices, 0.6 mm isotropic resolution, acquisition time = 10 min) was obtained using a 32-element (32Rx/1Tx) 1H head coil (Siemens).
Pre-processing
Sodium images were reconstructed offline in Matlab (Mathworks, Natick, MA) using a Kaiser-Bessel gridding method29 leading to a full 3D data set for each individual, at each echo time (See Fig. 1 for an example). 23Na images from all TEs were realigned to the shortest TE (0.3 ms) for each individual. 3D 23Na images from the shortest TE were then realigned to high resolution 3D-MP2RAGE images obtained from the same individual and the resulting spatial transform was applied to the remaining 23Na images (SPM12; Wellcome Institute, London, UK). Subsequent analyses using ROIs (see below) were applied to these coregistered 23Na-MRI images in the native 3D-MP2RAGE space. Figure 2 provides an overview of the workflow applied to data.
Using SPM12, 1H images were segmented into probability maps of GM, WM and CSF to create masks to be applied to sodium images. A conservative probability threshold of 0.9 for tissue type segmentation was applied to GM and WM prior to the creation of masks. FSL (version 6.0, FMRIB, Oxford, UK) was used to define 8 regional sub-cortical ROIs using 1H images, thresholded GM and WM maps and 23Na images of the earliest (high SNR) TE (0.3 ms). Sodium images and thresholded tissue probability maps were projected onto 1H images to aid expert (S.G.) manual definition of ROIs for each individual. In addition to thresholding of tissue probability maps attempts to limit partial volume effects included the avoidance of tissue boundaries and evident areas of heightened signal due to the proximity of CSF spaces such as the ventricles during manual ROI definition (Fig. 2). In total, 10 ROIs were applied for each individual to derive mean 23Na signal (MARSBAR toolbox, SPM12) for each ROI for each echo time. ROIs correspond to the entire (thresholded) GM and WM segmentations, in addition to eight sub-cortical manual bilateral ROIs: thalamus, pallidum, putamen, caudate nucleus, corpus callosum, centrum semiovale, cerebellar white matter and pons.
Biexponential model
Considering the design of the sodium sequence providing a maximum reduction of T1 weighting (TR = 120 ms, around four times longer than the T1 values7), determination of signal fractions and the time constants of short and long T2* components of signal decay in 23Na images can be modelled by a bi-exponential fitting procedure. For each ROI, we analysed the mean signal intensity across each of the 24 TEs and apply a biexponential model to the obtained curve (Fig. 2a) using the equation:
where A is an amplitude scaling term, f is the signal fraction associated with the short T2* component and Ric refers to a Rician noise-related scaling parameter as described in Gudbjartsson et al.53. The best-fit parameters were obtained from nonlinear least-squares (lsqnonlin) fitting. Model performance was measured by goodness of fit (r2). From the model we estimated a signal fraction for short (f) and long (1-f) T2* components, as well as estimating the time constants (T2*short and T2*long). We calculated magnetization (M0) corresponding to the signal fraction estimated by the model in terms of the intercepts of the signal fraction components of the model, obtaining M0SF = A·f and M0LF = A·(1-f).
Quantification: NaSF & NaLF
As these signal fraction parameters are expressed in arbitrary units, we attempted to obtain quantitative values to access the same measurement scale across subject in order to explore variations in tissue types and regions, and permit literature comparisons. For each reference tube for each individual, we obtained the value of M0 and the time of transverse relaxation (T2*) for a given tube across the 24 TEs, through monoexponential fitting via MATLAB (R2012a, MathWorks) (Fig. 2b). We then model a linear relationship between obtained M0 and known concentrations across all tubes (Fig. 2c), which can be applied to parameters estimated from the biexponential model of in vivo data (M0SF and M0LF, Fig. 2a). As such, the apparent concentrations equivalent to a given level of magnetization was obtained, yielding quantitative estimates (NaSF and NaLF) for each brain ROI. Note that given that we have dynamic information in the form of the curve of signal intensity across TEs, we can hypothesize that at the longest TEs, the major signal contributors will be the slowest relaxing/most motile pools. Accordingly, the magnetization estimated from the intercept of the signal fraction associated with the long T2* component may be considered a good approximation of the sodium concentration of extracellular spaces. ‘Extracellular fraction’ (EcF) was obtained by the division of NaLF by the commonly used value of 140 mM for extracellular Na concentration7,15,54. We also calculated the parameter total sodium concentration (TSC) as the sum of NaSF and NaLF.
Statistical analyses
Six dependant variables of interest were investigated via analysis in JMP v.9 (SAS Institute Inc., Cary, NC). These included T2*short and T2*long (ms) derived from the biexponential fitting procedure, the quantitative estimates NaSF and NaLF,(mM), as well as TSC (mM) and EcF. An ANOVA was applied separately to the six dependant variables to investigate the factor of interest Tissue Type (2 levels: GM, WM), in addition to factors for Sex and Age. Additionally, an ANOVA was applied to the sub-cortical regional data, with the factor of interest Region (8 levels) as well as Sex and Age. Differences between the levels of factors of interest that were found to be significant were further investigated via non-parametric Steel-Dwass (p < 0.05, adjusted for multiple comparisons between levels) in a pairwise fashion. Based on the possibility of dependence between measures, Bonferroni correction was also applied across tests based on 6 dependant variables yielding a corrected α-level of P = 0.05/6 = 0.008.
Data Availability
Generated datasets are available on reasonable request from the corresponding author.
Acknowledgements
This work was supported by the ANR grant JCJC ‘NEUROintraSOD-7T’ (ANR-15-CE19-0019-01) as well as the Equipex 7T-AMI (ANR-11-EQPX-0001) and A*midex 7T-Amistart (ANR-11-IDEX-0001-02) programs.
Author Contributions
B.R., M.B., J-P.R. and W.Z. designed the experiments. A.N. and M.B. implemented the multi-echo sequence in the Siemens scanner. B.R., M.B., S.B., P.V., J.V., J.-P.R. and W.Z. contributed to the acquisition, processing and analysis of data. B.R., A.N., M.B., A.M. J.-P.S., S.G., J.V., P.V., M.G., J.-P.R. and W.Z. interpreted the results and contributed to the final manuscript. All authors reviewed the manuscript.
Competing Interests
The authors declare no competing interests.
Footnotes
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Chatton J-Y, Magistretti PJ, Barros LF. Sodium signaling and astrocyte energy metabolism. Glia. 2016;64:1667–1676. doi: 10.1002/glia.22971. [DOI] [PubMed] [Google Scholar]
- 2.Madelin G, Lee J-S, Regatte RR, Jerschow A. Sodium MRI: methods and applications. Prog. Nucl. Magn. Reson. Spectrosc. 2014;79:14–47. doi: 10.1016/j.pnmrs.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thulborn KR. Quantitative Sodium MR Imaging: A Review of its Evolving Role in Medicine. NeuroImage. 2016 doi: 10.1016/j.neuroimage.2016.11.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Madelin G, Kline R, Walvick R, Regatte RR. A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging. Sci. Rep. 2014;4:4763. doi: 10.1038/srep04763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tsang A, et al. Relationship between sodium intensity and perfusion deficits in acute ischemic stroke. J. Magn. Reson. Imaging. 2011;33:41–47. doi: 10.1002/jmri.22299. [DOI] [PubMed] [Google Scholar]
- 6.Ridley B, et al. Brain sodium MRI in human epilepsy: Disturbances of ionic homeostasis reflect the organization of pathological regions. NeuroImage. 2017;157:173–183. doi: 10.1016/j.neuroimage.2017.06.011. [DOI] [PubMed] [Google Scholar]
- 7.Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology. 2003;227:529–537. doi: 10.1148/radiol.2272020483. [DOI] [PubMed] [Google Scholar]
- 8.Maarouf A, et al. Topography of brain sodium accumulation in progressive multiple sclerosis. Magma N. Y. N. 2014;27:53–62. doi: 10.1007/s10334-013-0396-1. [DOI] [PubMed] [Google Scholar]
- 9.Mellon EA, et al. Sodium MR imaging detection of mild Alzheimer disease: preliminary study. AJNR Am. J. Neuroradiol. 2009;30:978–984. doi: 10.3174/ajnr.A1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Petracca M, et al. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study. Brain J. Neurol. 2016;139:795–806. doi: 10.1093/brain/awv386. [DOI] [PubMed] [Google Scholar]
- 11.Reetz K, et al. Increased brain tissue sodium concentration in Huntington’s Disease - a sodium imaging study at 4 T. NeuroImage. 2012;63:517–524. doi: 10.1016/j.neuroimage.2012.07.009. [DOI] [PubMed] [Google Scholar]
- 12.Zaaraoui W, et al. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study. Radiology. 2012;264:859–867. doi: 10.1148/radiol.12112680. [DOI] [PubMed] [Google Scholar]
- 13.Bottomley, P. A. Sodium MRI in Man: Technique and Findings. in eMagRes., 10.1002/9780470034590.emrstm1252 (John Wiley & Sons, Ltd, 2007).
- 14.Madelin G, Regatte RR. Biomedical applications of sodium MRI in vivo. J. Magn. Reson. Imaging JMRI. 2013;38:511–529. doi: 10.1002/jmri.24168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ouwerkerk R. Sodium MRI. Methods Mol. Biol. Clifton NJ. 2011;711:175–201. doi: 10.1007/978-1-61737-992-5_8. [DOI] [PubMed] [Google Scholar]
- 16.Stobbe R, Beaulieu C. In vivo sodium magnetic resonance imaging of the human brain using soft inversion recovery fluid attenuation. Magn. Reson. Med. 2005;54:1305–1310. doi: 10.1002/mrm.20696. [DOI] [PubMed] [Google Scholar]
- 17.Kline RP, et al. Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2000;6:2146–2156. [PubMed] [Google Scholar]
- 18.Nagel AM, et al. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest. Radiol. 2011;46:539–547. doi: 10.1097/RLI.0b013e31821ae918. [DOI] [PubMed] [Google Scholar]
- 19.Boada FE, Christensen JD, Huang-Hellinger FR, Reese TG, Thulborn KR. Quantitative in vivo tissue sodium concentration maps: the effects of biexponential relaxation. Magn. Reson. Med. 1994;32:219–223. doi: 10.1002/mrm.1910320210. [DOI] [PubMed] [Google Scholar]
- 20.Shah NJ, Worthoff WA, Langen K-J. Imaging of sodium in the brain: a brief review. NMR Biomed. 2016;29:162–174. doi: 10.1002/nbm.3389. [DOI] [PubMed] [Google Scholar]
- 21.Konstandin S, Nagel AM. Measurement techniques for magnetic resonance imaging of fast relaxing nuclei. Magma N. Y. N. 2014;27:5–19. doi: 10.1007/s10334-013-0394-3. [DOI] [PubMed] [Google Scholar]
- 22.Perman WH, Thomasson DM, Bernstein MA, Turski PA. Multiple short-echo (2.5-ms) quantitation of in vivo sodium T2 relaxation. Magn. Reson. Med. 1989;9:153–160. doi: 10.1002/mrm.1910090202. [DOI] [PubMed] [Google Scholar]
- 23.Perman WH, Turski PA, Houston LW, Glover GH, Hayes CE. Methodology of in vivo human sodium MR imaging at 1.5 T. Radiology. 1986;160:811–820. doi: 10.1148/radiology.160.3.3737922. [DOI] [PubMed] [Google Scholar]
- 24.Winkler SS, Thomasson DM, Sherwood K, Perman WH. Regional T2 and sodium concentration estimates in the normal human brain by sodium-23 MR imaging at 1.5 T. J. Comput. Assist. Tomogr. 1989;13:561–566. doi: 10.1097/00004728-198907000-00002. [DOI] [PubMed] [Google Scholar]
- 25.Bartha R, Menon RS. Long component time constant of 23Na T*2 relaxation in healthy human brain. Magn. Reson. Med. 2004;52:407–410. doi: 10.1002/mrm.20144. [DOI] [PubMed] [Google Scholar]
- 26.Fleysher L, Oesingmann N, Stoeckel B, Grossman RI, Inglese M. Sodium long-component T(2)(*) mapping in human brain at 7 Tesla. Magn. Reson. Med. 2009;62:1338–1341. doi: 10.1002/mrm.22133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Niesporek SC, et al. Improved T2* determination in (23)Na, (35)Cl, and (17)O MRI using iterative partial volume correction based on (1)H MRI segmentation. Magma N. Y. N. 2017 doi: 10.1007/s10334-017-0623-2. [DOI] [PubMed] [Google Scholar]
- 28.Blunck Y, et al. 3D-multi-echo radial imaging of (23) Na (3D-MERINA) for time-efficient multi-parameter tissue compartment mapping. Magn. Reson. Med. 2017 doi: 10.1002/mrm.26848. [DOI] [PubMed] [Google Scholar]
- 29.Nagel AM, et al. Sodium MRI using a density-adapted 3D radial acquisition technique. Magn. Reson. Med. Off. J. Soc. Magn. Reson. Med. Soc. Magn. Reson. Med. 2009;62:1565–1573. doi: 10.1002/mrm.22157. [DOI] [PubMed] [Google Scholar]
- 30.Deoni SCL. Quantitative relaxometry of the brain. Top. Magn. Reson. Imaging TMRI. 2010;21:101–113. doi: 10.1097/RMR.0b013e31821e56d8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kraff O, Fischer A, Nagel AM, Mönninghoff C, Ladd ME. MRI at 7 Tesla and above: demonstrated and potential capabilities. J. Magn. Reson. Imaging JMRI. 2015;41:13–33. doi: 10.1002/jmri.24573. [DOI] [PubMed] [Google Scholar]
- 32.Nagel AM, et al. 39) K and (23) Na relaxation times and MRI of rat head at 21.1 T. NMR Biomed. 2016;29:759–766. doi: 10.1002/nbm.3528. [DOI] [PubMed] [Google Scholar]
- 33.Qian Y, et al. Short-T2 imaging for quantifying concentration of sodium ((23) Na) of bi-exponential T2 relaxation. Magn. Reson. Med. 2014 doi: 10.1002/mrm.25393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Madelin G, Babb J, Xia D, Regatte RR. Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T. PloS One. 2015;10:e0118692. doi: 10.1371/journal.pone.0118692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fleysher L, et al. Noninvasive quantification of intracellular sodium in human brain using ultrahigh-field MRI. NMR Biomed. 2013;26:9–19. doi: 10.1002/nbm.2813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Syková E, Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008;88:1277–1340. doi: 10.1152/physrev.00027.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Inglese M, et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain J. Neurol. 2010;133:847–857. doi: 10.1093/brain/awp334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Paling D, et al. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain J. Neurol. 2013;136:2305–2317. doi: 10.1093/brain/awt149. [DOI] [PubMed] [Google Scholar]
- 39.Qian Y, Zhao T, Zheng H, Weimer J, Boada FE. High-resolution sodium imaging of human brain at 7 T. Magn. Reson. Med. 2012;68:227–233. doi: 10.1002/mrm.23225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Eisele P, et al. Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI. Mult. Scler. Houndmills Basingstoke Engl. 2016;22:1040–1047. doi: 10.1177/1352458515609430. [DOI] [PubMed] [Google Scholar]
- 41.Niesporek SC, et al. Partial volume correction for in vivo 23Na-MRI data of the human brain. NeuroImage. 2015;112:353–363. doi: 10.1016/j.neuroimage.2015.03.025. [DOI] [PubMed] [Google Scholar]
- 42.Koessler L, et al. In-vivo measurements of human brain tissue conductivity using focal electrical current injection through intracerebral multicontact electrodes. Hum. Brain Mapp. 2017;38:974–986. doi: 10.1002/hbm.23431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn. Reson. Med. 2001;45:71–79. doi: 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
- 44.Krebs N, et al. Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry. J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elem. GMS. 2014;28:1–7. doi: 10.1016/j.jtemb.2013.09.006. [DOI] [PubMed] [Google Scholar]
- 45.Nicholson C, Kamali-Zare P, Tao L. Brain Extracellular Space as a Diffusion Barrier. Comput. Vis. Sci. 2011;14:309–325. doi: 10.1007/s00791-012-0185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Pelvig DP, Pakkenberg H, Stark AK, Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging. 2008;29:1754–1762. doi: 10.1016/j.neurobiolaging.2007.04.013. [DOI] [PubMed] [Google Scholar]
- 47.von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting. J. Comp. Neurol. 2016;524:3865–3895. doi: 10.1002/cne.24040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mota B, Herculano-Houzel S. All brains are made of this: a fundamental building block of brain matter with matching neuronal and glial masses. Front. Neuroanat. 2014;8:127. doi: 10.3389/fnana.2014.00127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Herculano-Houzel S. The glia/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia. 2014;62:1377–1391. doi: 10.1002/glia.22683. [DOI] [PubMed] [Google Scholar]
- 50.Azevedo FAC, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 2009;513:532–541. doi: 10.1002/cne.21974. [DOI] [PubMed] [Google Scholar]
- 51.Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J. Mol. Neurosci. MN. 2008;34:51–61. doi: 10.1007/s12031-007-0029-0. [DOI] [PubMed] [Google Scholar]
- 52.Goodman JA, Kroenke CD, Bretthorst GL, Ackerman JJH, Neil JJ. Sodium ion apparent diffusion coefficient in living rat brain. Magn. Reson. Med. 2005;53:1040–1045. doi: 10.1002/mrm.20444. [DOI] [PubMed] [Google Scholar]
- 53.Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn. Reson. Med. 1995;34:910–914. doi: 10.1002/mrm.1910340618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Thulborn KR, Davis D, Adams H, Gindin T, Zhou J. Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn. Reson. Med. 1999;41:351–359. doi: 10.1002/(SICI)1522-2594(199902)41:2<351::AID-MRM20>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Generated datasets are available on reasonable request from the corresponding author.